Head-to-head · Cost-Efficiency Index
NiceRx vs Vytora Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NiceRx
Cost-first shoppers who want a clearly disclosed standing month-to-month rate rather than a prepay-gated one.
Visit NiceRxVytora Health
Shoppers who want flat per-dose pricing with a named pharmacy and an optional brand-name fallback, 50 states.
Visit Vytora HealthThe verdict
NiceRx and Vytora Health tie on the Cost-Efficiency Index at 76/100, so neither wins outright on the numbers. For most shoppers we'd start with NiceRx (ranked #50, a hair above #51) — Cost-first shoppers who want a clearly disclosed standing month-to-month rate rather than a prepay-gated one. But Vytora Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NiceRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NiceRx | Vytora Health |
|---|---|---|
| Cost-Efficiency Index | 76/100 | 76/100 |
| Semaglutide / mo | $199/mo (all doses, compounded) | $179/mo (all doses, compounded) |
| Tirzepatide / mo | $299/mo (all doses, compounded) | $199/mo (all doses, 3-month plan, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,148 |
| Tirzepatide / yr (modeled) | $3,588 | $2,388 |
| Coverage | 46 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #50 | #51 |
NiceRx
76/100Where the value is
- Explicitly discloses both the promotional first-month price and the real ongoing 'every month thereafter' rate on the same page, rather than only advertising the promo
- Flat pricing across all doses, with the provider visit and shipping bundled into the price
- Cancel-anytime billing with no long-term commitment structure found
The tradeoffs
- Not available in Alaska, Mississippi, New Jersey, or Kansas
- Compounded only — no FDA-approved brand option
Vytora Health
76/100Where the value is
- Semaglutide pricing is genuinely flat across all doses, not a 'starting at' floor
- 50 states plus DC covered, with per-state video-vs-audio requirements disclosed rather than hidden
- Both compounded and retail brand-name (Mounjaro, Zepbound) options on one platform
The tradeoffs
- The site's own FAQ and pricing page disagree on the 1-month tirzepatide price ($199 vs $249) — get the number confirmed at checkout before assuming either figure
- Brand-name Mounjaro/Zepbound at $1,399/mo is essentially full retail
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.